"What" Series
What is DSMB?
28 September 2023
2 min read
DSMB stands for Data Safety and Monitoring Board, an independent expert group established to safeguard the rights and needs of infants and young children participating in Phase III clinical trials. This board ensures that the trial meets the highest standards in professional ethics and patient care, and adheres to international standards of good clinical practice.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Keep Reading
Back to all blogs →
Latest Hotspot
3 min read
Antengene Declares Phase I Trial for ATG-031, an Anti-CD24 Monoclonal Antibody
28 September 2023
Antengene Corp Ltd obtained approval from University of Texas MD Anderson Cancer Center's Institutional Review Board for a Phase I trial of its prime anti-CD24 antibody, ATG-031, focusing on advanced hematology and oncology solutions.
"What" Series
2 min read
What is MAH in Life Sciences?
28 September 2023
The full name is Marketing Authorization Holder. This typically refers to entities such as drug development institutions that possess drug technology, scientific researchers, and pharmaceutical manufacturing enterprises.
Drug Insights
4 min read
Pharmaceutical Insights: Ephedrine Sulfate's R&D Progress and its Mechanism of Action on Drug Target
3 October 2023
This article summarized the latest R&D progress of Ephedrine Sulfate, the Mechanism of Action for Ephedrine Sulfate, and the drug target R&D trends for Ephedrine Sulfate.
Drug Insights
4 min read
Exploring Fluphenazine Decanoate's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
3 October 2023
This article summarized the latest R&D progress of Fluphenazine Decanoate, the Mechanism of Action for Fluphenazine Decanoate, and the drug target R&D trends for Fluphenazine Decanoate.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.